STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era

Data from the Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial(6) and 5-year results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI)(7) are evaluated for further evidence on the effectiveness and safety of a pharmacoinvasive a...

Descripción completa

Detalles Bibliográficos
Autor principal: ElGuindy, Ahmed M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bloomsbury Qatar Foundation Journals 2014
Materias:
Lessons from the Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220436/
https://www.ncbi.nlm.nih.gov/pubmed/25405180
http://dx.doi.org/10.5339/gcsp.2014.27
_version_ 1782342734983462912
author ElGuindy, Ahmed M.
author_facet ElGuindy, Ahmed M.
author_sort ElGuindy, Ahmed M.
collection PubMed
description Data from the Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial(6) and 5-year results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI)(7) are evaluated for further evidence on the effectiveness and safety of a pharmacoinvasive approach for patients presenting with acute ST-segment elevation myocardial infarction (STEMI).
format Online
Article
Text
id pubmed-4220436
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Bloomsbury Qatar Foundation Journals
record_format MEDLINE/PubMed
spelling pubmed-42204362014-11-17 STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era ElGuindy, Ahmed M. Glob Cardiol Sci Pract Lessons from the Trials Data from the Strategic Reperfusion Early After Myocardial Infarction (STREAM) trial(6) and 5-year results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI)(7) are evaluated for further evidence on the effectiveness and safety of a pharmacoinvasive approach for patients presenting with acute ST-segment elevation myocardial infarction (STEMI). Bloomsbury Qatar Foundation Journals 2014-06-18 /pmc/articles/PMC4220436/ /pubmed/25405180 http://dx.doi.org/10.5339/gcsp.2014.27 Text en © 2014 ElGuindy, licensee Bloomsbury Qatar Foundation Journals. This is an open access article distributed under the terms of the Creative Commons Attribution license CC BY 4.0, which permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Lessons from the Trials
ElGuindy, Ahmed M.
STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
title STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
title_full STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
title_fullStr STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
title_full_unstemmed STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
title_short STREAM and FAST-MI – Pharmacoinvasive therapy: A continued role for fibrinolysis in the primary PCI era
title_sort stream and fast-mi – pharmacoinvasive therapy: a continued role for fibrinolysis in the primary pci era
topic Lessons from the Trials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220436/
https://www.ncbi.nlm.nih.gov/pubmed/25405180
http://dx.doi.org/10.5339/gcsp.2014.27
work_keys_str_mv AT elguindyahmedm streamandfastmipharmacoinvasivetherapyacontinuedroleforfibrinolysisintheprimarypciera

Ejemplares similares